Delivery Order SPE2DB22D3301-SPE2DB24FZ3QS

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,705.51 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of 4,563,971,856 units of the prescription drug Lyrica 100 mg capsules. The delivery order was issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999 and a performance period through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,454.04 to provide Lyrica 75 mg capsules. This award is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 100 mg capsules. The contract has a ceiling value of $1,647.67 and a period of performance through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 150 mg capsules. The contract has a firm fixed price of $1,086.30 and a performance period ending on July 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,133.45, is for the supply of 4,565,938,887 units of Lyrica 75 mg capsules. The contract is a firm-fixed-price delivery order with a completion date of September 26, 2024. It is not a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count bottles of the 300 mg Lyrica capsule medication. The $1,446.17 delivery order, which has a completion date of February 2, 2024, is not designated as a set-aside contract. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lyrica 150 mg capsules. The contract has a firm fixed price of $3,459.54 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lyrica 50 mg capsules. The contract has a ceiling value of $10,532.81 and a performance period through April 10, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,159.24 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Lyrica 25 mg capsules. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,364.43 contract is for the delivery of Lyrica 50 mg capsules, with a performance period through February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ3QS
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,768.15 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565602832 - Lyrica 100 mg capsules (90 count) and does not have a set-aside designation. This delivery order contract is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 28, 2024.

Generated 11/26/24, 9:15 AM